Cargando…

Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism

BACKGROUND: There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolipoprotein(a) polymorphism are associated with angiographically assessed asymptom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gazzaruso, Carmine, Garzaniti, Adriana, Giordanetti, Stefano, Falcone, Colomba, Fratino, Pietro
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2002
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149426/ https://www.ncbi.nlm.nih.gov/pubmed/12473160 http://dx.doi.org/10.1186/1475-2840-1-5

Ejemplares similares

Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes
por: Gazzaruso, Carmine, et al.
Publicado: (2016)

Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
por: Falcone, Colomba, et al.
Publicado: (2013)

Transcutaneous Oxygen Tension as a Potential Predictor of Cardiovascular Events in Type 2 Diabetes: Comparison with ankle-brachial index
por: Gazzaruso, Carmine, et al.
Publicado: (2013)

Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis
por: Sadeghi, Hamid Mirmohammad, et al.
Publicado: (2011)

Prognostic implications of calculated Apo‐lipoprotein B in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcome is tied to lower cut‐points
por: Ghodsi, Saeed, et al.
Publicado: (2021)

Lipoprotein(a), homocysteine, and retinal arteriosclerosis
por: Ghorbanihaghjo, Amir, et al.
Publicado: (2008)

Impact of convalescent and nonimmune plasma on mortality of patients with COVID-19: a potential role for antithrombin
por: Gazzaruso, Carmine, et al.
Publicado: (2021)

Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study
por: Tani, Shigemasa, et al.
Publicado: (2017)

The Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients
por: Shidfar, Farzad, et al.
Publicado: (2012)

Association of Homocysteine, Methionine, and MTHFR 677C>T Polymorphism With Rate of Cardiovascular Multimorbidity Development in Older Adults in Sweden
por: Calderón-Larrañaga, Amaia, et al.
Publicado: (2020)

Plasma homocysteine levels are related to medium-term venous graft degeneration in coronary artery bypass graft patients
por: Balogh, Emília, et al.
Publicado: (2016)

Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice
por: Zhu, Lin, et al.
Publicado: (2014)

Homocysteine levels in normotensive children of hypertensive parents
por: Yıldırım, Ali, et al.
Publicado: (2016)

Biofilms, Lipoprotein Aggregates, Homocysteine, and Arterial Plaque Rupture
por: Ravnskov, Uffe, et al.
Publicado: (2014)

Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects
por: Emanuele, Enzo, et al.
Publicado: (2003)

Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus
por: Shen, Ying, et al.
Publicado: (2015)

Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
por: Valensi, Paul, et al.
Publicado: (2016)

Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles
por: Amor, Antonio J., et al.
Publicado: (2020)

Association of Genetically Enhanced Lipoprotein Lipase–Mediated Lipolysis and Low-Density Lipoprotein Cholesterol–Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes
por: Lotta, Luca A., et al.
Publicado: (2018)

Elevated serum lipoprotein(a) is significantly associated with angiographic progression of coronary artery disease
por: Shui, Xing, et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

Elevated Homocysteine Intensify the Effect of Lipoprotein(a) on Stroke Recurrence
por: Feng, Zhiyuan, et al.
Publicado: (2022)

APOE Gene Polymorphism and Risk of Coronary Stenosis in Pakistani Population
por: Cheema, Asma Naseer, et al.
Publicado: (2015)

Silent Hypoxia in COVID-19: A Case Series
por: Fuehner, Thomas, et al.
Publicado: (2022)

Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion
por: Ferrazzi, Paola, et al.
Publicado: (2005)

APP-Induced Patterned Neurodegeneration Is Exacerbated by APOE4 in Caenorhabditis elegans
por: Sae-Lee, Wisath, et al.
Publicado: (2020)

Coalition of DNA polymorphisms of ApoB and ApoAI genes is related with coronary artery disease in Kazaks
por: Huang, Gang, et al.
Publicado: (2012)

Homocysteine, Cortisol, Diabetes Mellitus, and Psychopathology
por: Kontoangelos, K., et al.
Publicado: (2015)

Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention
por: Huang, Zhuoshan, et al.
Publicado: (2020)

Association between lipoprotein(a) and peripheral arterial disease in coronary artery bypass grafting patients
por: Yi, Cheng, et al.
Publicado: (2023)

Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
por: Wu, Hongyan, et al.
Publicado: (2021)

Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus
por: Markus, Marcello Ricardo Paulista, et al.
Publicado: (2021)

The screening power of methylenetetrahydrofolate reductase C677T polymorphism versus plasma homocysteine concentration in patients with stenosis of the internal carotid artery
por: Loncar, Robert, et al.
Publicado: (2006)

Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk
por: Drewes, Yvonne M, et al.
Publicado: (2014)

Apo Lipoprotein A1 Gene Polymorphisms Predict Cardio-Metabolic Risk in South Asian Immigrants
por: Dodani, Sunita, et al.
Publicado: (2012)

Association of Methylenetetrahydrofolate Reductase (MTHFR 677C>T and 1298A>C) Polymorphisms and Haplotypes with Silent Brain Infarction and Homocysteine Levels in a Korean Population
por: Han, In Bo, et al.
Publicado: (2010)

Gene polymorphism of 3'APO-VNTR in Egyptians with coronary artery disease
por: Elmougy, Rehab
Publicado: (2021)

Association of APOE Genotypes and Chronic Traumatic Encephalopathy
por: Atherton, Kathryn, et al.
Publicado: (2022)

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
por: Lebherz, Corinna, et al.
Publicado: (2007)

Lipid transfer to high‐density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events
por: Barbosa, Carlos J.D.G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fjrddemos0rjeugf4b91pefgb8